S

Sleep Therapy and Research Center | Medical Center Drive Office

Research site

Location

5290 Medical Drive, San Antonio, Texas, United States of America

Site insights

Top conditions

Top treatments

TAK-861

Atomoxetine

ADX-N05

E2086

Aroxybutynin

Armodafinil

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Active trials

2 of 15 total trials

A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

The main aim is to evaluate the safety and tolerability of TAK-861 in participants with type 1 narcolepsy, who were exposed to previously tested dose...

Enrolling

Narcolepsy Type 1

Drug: TAK-861

Continuation Protocol for Obstructive Sleep Apnea (OSA)

The combination drug composed of aroxybutynin and atomoxetine, designated AD109, is being developed by Apnimed for the treatment of obstructive sleep...

Invitation-only

OSA

Drug: Aroxybutynin and Atomoxetine